Soterix Medical Receives FDA Clearance for Innovative SPRY TMS Therapy in Major Depression Treatment Soterix Medical has announced FDA clearance for the SPRY TMS Therapy, an advanced treatment for Major Depression, enhancing patient care.

Soterix Medical Receives FDA Clearance for Innovative SPRY TMS Therapy in Major Depression Treatment #United_States #Woodbridge #Soterix_Medical #SPRY_TMS #Major_Depression